Flow Cytometry News and Research

RSS

Flow cytometry is a technique for counting and examining microscopic particles suspended in a stream of fluid. It allows simultaneous multiparametric analysis of the physical and/or chemical characteristics of single cells flowing through an optical and/or electronic detection apparatus.

New low-cost microfluidic device brings single-cell technology to bedside

Single-cell analysis holds enormous potential to study how individual cells influence disease and respond to treatment, but the lack of cost-effective and user-friendly instrumentation remains challenging.

23 Feb 2018

Soil-dwelling bacterium produces potential weapon against melanoma

A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows.

4 Jan 2018

Overcoming Challenges of Assays of Complex Cellular Models with Real-Time Live-Cell Analysis

There's a continued drive towards making in vitro assays ever more translational towards in vivo models and ultimately the clinic. This ties in with the resurgence of phenotypic screening and is a response to the perceived poor translation of the traditional simple cell-based assays, often developed to study just single protein targets.

From Sartorius 5 Dec 2017

Study provides potential explanation for increased prevalence of asthma in adult women

In childhood, asthma is more common in boys than girls. But around the time of puberty, that picture reverses. By midlife women are twice as likely as men to have asthma.

29 Nov 2017

Adipocytes may reduce effectiveness of chemotherapeutic drug

Adipocytes, or fat cells, can absorb and metabolize the chemotherapeutic agent daunorubicin, reducing the effectiveness of the drug and potentially contributing to poorer treatment outcomes.

8 Nov 2017

Newly developed tool to analyze synovial tissue may lead to better rheumatoid arthritis therapies

A newly developed tool to analyze the cellular and molecular profiles of synovial tissue and peripheral blood may help unlock clues about rheumatoid arthritis and lead to better therapies, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Blood samples may help identify most sensitive patients before radiation and chemotherapy

How much radiation or chemotherapy can a certain person handle? With help from blood or tissue testing, it may be possible to answer this question in advance, which in turn could improve treatment, as research at Sahlgrenska Academy shows.

9 Oct 2017

Novel assay shows potential to detect circulating cancer biomarkers in blood samples

Future Science Group today announced the publication of an article in Future Science OA presenting early data from a novel assay for the non-invasive detection of PD-L1 and other biomarkers in patient blood samples.

22 Sep 2017

Seeing the full picture, real-time analysis of live-cells

Every cell is a miniature factory taking in raw material (extracellular signals) and processing it to produce something (a biological response). But unlike a factory that can be easily tweaked to run at steady-state and look the same from day to day, cells are dynamic.

From Sartorius 7 Sep 2017

Researchers define how cancer drug works in cells, mice and man

Science is very good at determining how drugs work in experimental models. New research out of Dartmouth's Norris Cotton Cancer Center led by Alan Eastman, PhD, helps to bridge the gap when it comes to ensuring that drugs work by the same mechanism in human patients.

7 Sep 2017

First flow cytometer offering excitation sources across the visible spectrum launched by Beckman Coulter

Opening possibilities for cancer researchers with first flow cytometer to offer excitation sources across the visible spectrum in a standard configuration.

From Beckman Coulter Life Sciences - Flow Cytometry 6 Sep 2017

Distinguishing biothreat look-alikes could aid biological surveillance

Biological "detectives" are tracking down biothreats such as the bacteria that causes tularemia ("rabbit fever"), but they constantly face the challenge of avoiding false positives.

26 Aug 2017

Researchers develop quick and easy-to-use test for detecting rare immunodeficiency

Researchers at the University of Basel have developed a test to quickly and reliably diagnose a rare and severe immune defect, hepatic veno-occlusive disease with immunodeficiency. They reported on their findings in the Journal of Clinical Immunology.

22 Aug 2017

Newest addition to Hamilton's PSD/4 precision syringe drive product family announced

Hamilton Company expands its PSD/4 precision syringe drive product family with the launch of PSD/4 Smooth Flow. The new PSD/4 Smooth Flow delivers exact flow rates in nanoliters per minute with total dispense times up to 8 hours. They are perfect for engineers looking for an economical way to automate processes that were developed on lab scale pumps.

From Hamilton Company 1 Aug 2017

Expanding clinical flow cytometry portfolio unveiled by Beckman Coulter at AACC

Beckman Coulter Life Sciences unveils its expanding clinical flow cytometry portfolio at the 69th American Association for Clinical Chemistry.

From Beckman Coulter Life Sciences - Flow Cytometry 28 Jul 2017

Illumina and Bio‑Rad introduce first next-generation sequencing solution for single-cell analysis

Illumina, Inc. and Bio‑Rad Laboratories, Inc. today announced the launch of the Illumina Bio-Rad Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco.

26 Jul 2017

Researchers devise strategy to target Achilles heel of nervous system cancers

Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment.

21 Jul 2017

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.

From Beckman Coulter Life Sciences - Flow Cytometry 14 Jul 2017

FDA authorizes marketing of test to aid in diagnoses of serious cancers

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

29 Jun 2017

New handbook reveals how live-cell analysis technology empowers research

From the moment cells are placed in culture, whether freshly harvested or defrosted from a cryovial, the learning opportunity begins.

From Sartorius 28 Jun 2017